(TSX-V:RBX), NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE U.S. QUÉBEC CITY, Jan. 21, 2025 (GLOBE NEWSWIRE) — Robex Resources Inc. (TSXV: RBX) (“Robex” or the “Company“) is pleased to announce that is has engaged a lead agent to offer for sale to the public, on a “best efforts” agency basis, up […]

MIAMI, Jan. 21, 2025 (GLOBE NEWSWIRE) — Defiance ETFs is thrilled to announce that QTUM–Defiance Quantum Computing ETF has reached a major milestone, surpassing $1 billion in assets under management (AUM), a testament to the growing momentum behind quantum computing. QTUM is up over 50% in 2024 (as of 12-31-24). Visit www.defianceetfs.com/qtum/#standardized-performance for standardized performance.

(NASDAQ:KSPI), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) between January 19, 2024 and September 19, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline in the

(NYSE:CUBI), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Customers Bancorp, Inc. (NYSE: CUBI) between March 1, 2024 and August 8, 2024, both dates inclusive (the “Class Period”), of the January 31, 2025 lead plaintiff deadline in the securities class

PHILADELPHIA, PA / ACCESS Newswire / January 21, 2025 / abrdn Emerging Markets Equity Income Fund, Inc. (NYSE American:AEF), a non-diversified closed-end fund, announced today the commencement of the previously announced cash tender offer to purchase up to 10,150,355 shares, representing approximately 20% of the Fund’s outstanding shares, at a price per share equal to

(NASDAQ:MGPI), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MGP Ingredients, Inc. (NASDAQ: MGPI) between May 4, 2023 and October 30, 2024 (the “Class Period”), of the important February 14, 2025 lead plaintiff deadline. SO WHAT: If you purchased

(NASDAQ:XLO), 27% preliminary response rate observed in heavily pre-treated microsatellite stable colorectal cancer (MSS CRC) patients without liver metastases Responses were accompanied by decreases in levels of carcinoembryonic antigen (CEA) and circulating tumor DNA (ctDNA) and improvement in clinical symptoms Data continue to demonstrate differentiated safety and tolerability profile for the combination with low incidence

(TSX:ETG),(OTC US:ERLFF),(OTCQB:ERLFF), NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 21, 2025 (GLOBE NEWSWIRE) — Entree Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entree“) is pleased to announce a non-brokered private placement of up to an aggregate 2,577,700 units of the Company

Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology and rare diseases, today announced preliminary efficacy and safety data from the Phase 1 trial of ozekibart (INBRX-109) in combination with FOLFIRI for the treatment of advanced or metastatic, unresectable colorectal adenocarcinoma (CRC). These results were

Galaxy Digital Holdings Ltd. (TSX: GLXY)(“Galaxy”) announced that its affiliate, Galaxy Asset Management, (“GAM”), reported preliminary assets under management of $5.7 billion as of December 31, 2024. The 6.5% decrease in preliminary AUM compared to the prior month was primarily driven by market depreciation and net outflows from GAM's Passive Funds. Note – we will